These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 19461820)

  • 1. The influence of prescription monitoring programs on chronic pain management.
    Wang J; Christo PJ
    Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
    Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
    Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
    Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
    Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of prescription monitoring programs for surveillance--analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006.
    Katz N; Panas L; Kim M; Audet AD; Bilansky A; Eadie J; Kreiner P; Paillard FC; Thomas C; Carrow G
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):115-23. PubMed ID: 20014166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources.
    Manchikanti L
    Pain Physician; 2006 Oct; 9(4):287-321. PubMed ID: 17066115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse of prescription and over-the-counter medications.
    Lessenger JE; Feinberg SD
    J Am Board Fam Med; 2008; 21(1):45-54. PubMed ID: 18178702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of prescription monitoring programs to reduce opioid diversion and improve patient safety.
    Morgan L; Weaver M; Sayeed Z; Orr R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):4-9. PubMed ID: 23190160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician perspectives on a pilot prescription monitoring program.
    Barrett K; Watson A
    J Pain Palliat Care Pharmacother; 2005; 19(3):5-13. PubMed ID: 16219606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion.
    Manchikanti L; Whitfield E; Pallone F
    Pain Physician; 2005 Oct; 8(4):335-47. PubMed ID: 16850056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids, pain management and the law.
    Stayner RS; Copenhaver DJ
    Curr Opin Anaesthesiol; 2012 Oct; 25(5):566-71. PubMed ID: 22914352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity.
    Manchikanti L; Brown KR; Singh V
    Pain Physician; 2002 Jul; 5(3):294-319. PubMed ID: 16902657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does adherence monitoring reduce controlled substance abuse in chronic pain patients?
    Manchikanti L; Manchukonda R; Damron KS; Brandon D; McManus CD; Cash K
    Pain Physician; 2006 Jan; 9(1):57-60. PubMed ID: 16700282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.
    Gilson AM; Maurer MA; Joranson DE
    J Pain; 2007 Sep; 8(9):682-91. PubMed ID: 17627894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.